It is therefore possible that the increased in vivo glycation of PON1 leads to its glyoxidation and reduction of activity, and is responsible for the derangement of membrane hydroperoxide metabolism found in HDL from people with diabetes. The gene discussed is PON1; the disease is diabetes mellitus.